Par Drugs and Chemicals Limited

NSEI:PAR Voorraadrapport

Marktkapitalisatie: ₹3.8b

Par Drugs and Chemicals Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Par Drugs and Chemicals heeft een totaal eigen vermogen van ₹967.6M en een totale schuld van ₹0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk ₹1.2B en ₹188.9M. De EBIT Par Drugs and Chemicals is ₹234.0M waardoor de rentedekking -103.9 is. Het heeft contanten en kortetermijnbeleggingen van ₹187.8M.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

₹0

Schuld

Rente dekkingsratio-103.9x
Contant₹187.82m
Aandelen₹967.61m
Totaal verplichtingen₹188.94m
Totaal activa₹1.16b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

There's No Escaping Par Drugs and Chemicals Limited's (NSE:PAR) Muted Earnings Despite A 26% Share Price Rise

Oct 29
There's No Escaping Par Drugs and Chemicals Limited's (NSE:PAR) Muted Earnings Despite A 26% Share Price Rise

Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified

Apr 16
Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified

Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Apr 05
Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?

Nov 03
Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?

If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity

May 19
If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity

Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?

Mar 17
Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?

Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?

Oct 22
Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?

Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings

Aug 11
Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings

Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching

Jul 14
Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching

Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?

Mar 31
Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?

Mar 05
Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?

Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)

Feb 06
Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)

Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Jan 10
Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?

Dec 13
How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₹490.6M ) PAR } overtreffen de korte termijn passiva ( ₹153.5M ).

Langlopende schulden: De kortetermijnactiva PAR ( ₹490.6M ) overtreffen de langetermijnschulden ( ₹35.4M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: PAR is schuldenvrij.

Schuld verminderen: PAR heeft geen schulden vergeleken met 5 jaar geleden, toen de schuld/eigen vermogen-ratio 15.6% was.

Schuldendekking: PAR heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: PAR heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.


Balans


Ontdek gezonde bedrijven